NEW research from the United States about the cost of menopause underlines the need for the Federal Govt to measure and report on its impact on women in Australia, according to the Australian Institute of Superannuation Trustees (AIST).
The study published by the Mayo Clinic estimated that menopause-related symptoms in the US cost women about $US26.6b ($A40.2b) in lost time from work and medical expenses annually.
The Impact of Menopause Symptoms on Women in the Workplace study identified an association between menopause symptoms and adverse work outcomes, including lost work productivity.
"Despite the universality of menopause and the important role women play as contributors to the global economy, there remains a dearth of literature on the impact of menopause symptoms on work productivity," the authors wrote.
The study covered 4,440 women who were employed and receiving primary care at Mayo Clinic, a non-profit academic medical centre.
The US study findings were welcomed by AIST, which has estimated severe menopausal symptoms cost Australian women $15.2b per year in lost earnings and superannuation due to early retirement.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 May 23
